Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H25N5O10.ClH |
Molecular Weight | 531.901 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@@]1(O[C@H]([C@H](O)[C@@H]1O)N2C=CC(=O)NC2=O)[C@H](NC(=O)[C@@H](N)[C@H](C)[C@H](O)C3=CC=C(O)C=N3)C(O)=O
InChI
InChIKey=HLFYQXGEGXXXIQ-FNRJKXLQSA-N
InChI=1S/C20H25N5O10.ClH/c1-7(13(28)9-3-2-8(26)6-22-9)11(21)17(31)24-12(19(32)33)16-14(29)15(30)18(35-16)25-5-4-10(27)23-20(25)34;/h2-7,11-16,18,26,28-30H,21H2,1H3,(H,24,31)(H,32,33)(H,23,27,34);1H/t7-,11-,12-,13-,14-,15+,16+,18+;/m0./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C20H25N5O10 |
Molecular Weight | 495.44 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Nikkomycin Z is an antifungal drug that inhibits chitin synthase. It has been reported that it inhibits chitin synthases (Chs) 1 and 3, but not 2, of Saccharomyces cerevisiae. Later it was found that nikkomycin Z inhibited all three Chs isozymes of Candida albicans (CaChs). The IC(50) value for CaChs1 is 15 uM, for CaChs2 0.8 uM, and for CaChs3 13 uM. Nikkomycin Z is under development as an orphan product for treatment of coccidioidomycosis. Nikkomycin Z has been used in trials studying the treatment and basic science of Coccidioidomycosis. In February 2006, nikkomycin z was designated as an orphan drug for the treatment of Coccidioidomycosis.
Originator
Sources: https://adisinsight.springer.com/drugs/800007285
Curator's Comment: Nikkomycin Z was first discovered by scientists at German pharmaceutical company, Bayer AG.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synergistic action of nikkomycins X and Z with papulacandin B on whole cells and regenerating protoplasts of Candida albicans. | 1986 Mar |
|
Synthesis and biological evaluation of dipeptidyl and tripeptidyl polyoxin and nikkomycin analogues as anticandidal prodrugs. | 1991 Jan |
|
Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo. | 1992 Jun |
|
Efficacy of nikkomycin Z in the treatment of murine histoplasmosis. | 1998 Sep |
|
In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. | 1999 Jun |
|
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. | 2000 Feb |
|
Drug interaction studies of a glucan synthase inhibitor (LY 303366) and a chitin synthase inhibitor (Nikkomycin Z) for inhibition and killing of fungal pathogens. | 2000 Sep |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19349517
Safety and pharmacokinetics of nikkomycin Z were evaluated in healthy male subjects following single, rising oral doses ranging from 250 mg to 2,000 mg. Pharmacokinetics appeared linear over the range of 250 to 500 mg; however, relative bioavailability was about 62 to 70% for the 1,000-mg dose and 42 to 47% for doses between 1,500 and 2,000 mg.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11870857
Nikkomycin Z inhibited all three Chs isozymes of Candida albicans (CaChs). The IC(50) value for CaChs1 is 15 uM, for CaChs2 0.8 uM, and for CaChs3 13 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:37:51 GMT 2023
by
admin
on
Fri Dec 15 15:37:51 GMT 2023
|
Record UNII |
09K02O611R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
76967378
Created by
admin on Fri Dec 15 15:37:51 GMT 2023 , Edited by admin on Fri Dec 15 15:37:51 GMT 2023
|
PRIMARY | |||
|
09K02O611R
Created by
admin on Fri Dec 15 15:37:51 GMT 2023 , Edited by admin on Fri Dec 15 15:37:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |